In addition, C. maxima albedo extract exhibited wide ranges of inhibitory properties against enzymes, which are drug targets for the treatment of AD (AChE, BChE, and BACE-1), obesity (lipase), and diabetes (α-glucosidase and α-amylase). This evidence concerns the gene BACE1 and Alzheimer disease.